U.S. Markets closed

Japan Starts Special Approval Process of Remdesivir: NHK

May.04 -- NHK is reporting that Japan has begun a special approval process for Remdesivir as a potential treatment for Covid-19. The move comes just after U.S. regulators cleared the drug for emergency use. Gilead, the drug maker, expects to have millions of courses available by the end of this year. Bloomberg’s Derek Wallbank reports on “Bloomberg Markets: China Open.”